Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.68 SEK | -3.20% | -3.20% | -13.73% |
May. 08 | Boule Diagnostics AB Appoints Rikke Rytter as Director | CI |
May. 07 | Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024 |
Sales 2024 * | 579M 53.4M | Sales 2025 * | 609M 56.17M | Capitalization | 376M 34.67M |
---|---|---|---|---|---|
Net income 2024 * | 35M 3.23M | Net income 2025 * | 43M 3.97M | EV / Sales 2024 * | 0.73 x |
Net Debt 2024 * | 47.3M 4.36M | Net Debt 2025 * | 40.53M 3.74M | EV / Sales 2025 * | 0.68 x |
P/E ratio 2024 * |
10.6
x | P/E ratio 2025 * |
8.56
x | Employees | 228 |
Yield 2024 * |
2.43% | Yield 2025 * |
3.56% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | -3.20% | ||
1 week | -3.20% | ||
Current month | -4.16% | ||
1 month | +1.26% | ||
3 months | -6.20% | ||
6 months | +2.98% | ||
Current year | -13.73% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | Dec. 31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 9.68 | -3.20% | 22,561 |
24-05-08 | 10 | +0.20% | 2,803 |
24-05-07 | 9.98 | +0.40% | 81,495 |
24-05-06 | 9.94 | -0.60% | 26,136 |
24-05-03 | 10 | 0.00% | 13,187 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.73% | 34.69M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- BOUL Stock